The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients
It is well established that several inflammatory-type conditions, such as arthritis, diabetes, cardiovascular disease, and irritable bowel disease exist comorbidly and at an increased incidence in patients with psoriasis. Psoriasis and other associated diseases are thought to share common inflammato...
Main Authors: | Mrowietz, Ulrich, Elder, James T., Barker, Jonathan |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer-Verlag
2006
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1705513/ |
Similar Items
-
Concomitant Sleep Disorders Significantly Increase the Risk of Cardiovascular Disease in Patients with Psoriasis
by: Chiu, Hsien-Yi, et al.
Published: (2016) -
The long-term efficacy and safety of new biological therapies for psoriasis
by: Papp, Kim A.
Published: (2006) -
Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest
by: Reich, K., et al.
Published: (2015) -
Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures
by: Koch, Manja, et al.
Published: (2015) -
Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
by: Kivelevitch, Dario, et al.
Published: (2014)